Table 11.
Choice of drug therapy in hypertensive patients with comorbid conditions - drugs that may have favorable effect on comorbid conditions
| Conditions | Drugs | Comments |
|---|---|---|
| Diabetes with proteinuria | ACEI, ARB,low dose diuretics,and longacting CCBs | |
| Stable Angina | β-blockersand CCBs, ACEI, ARB | If LVEF <30% verapamil and diltiazem should be avoided |
| Heart Failure | ACEI, ARB,carvedilol, sustained release metoprolol, diuretics | |
| Supraventricular tachycardia | β-blockersand non DHP CCBs | |
| Cough from ACEI | ARBs | ARBs couldbe used as substitution for ACEIs |
| Gout | ACEI, ARB,CCBs and β-blockers | |
| Dyslipidemia | ACEI, ARB,CCBs and α-blockers | |
| Essential tremor | Non-selective β-blockers | |
| Hyperthyroidism | Β-blockers | |
| Peripheral Vascular Disease | CCBs, ACEI,ARB | |
| Migraine | Β-blockersCCBs | |
| Osteoporosis | Thiazidediuretics | |
| Perioperative hypertension | Β-blockers | |
| Acute coronary syndrome | Β-blockers,ACEI, ARB | Ifβ-blockers are contraindicated, long acting DHP CCBs should be used. |
| Prostatism | Α-blockers | |
| Renal Insufficiency | ACEI, ARB,thiazide, loop diuretics | ACEI and ARBare contraindicated in bilateral renal artery stenosis |
| Elderly (> 65 years old) with no comorbid diseases | Diuretics,CCBs, ARBs, ACEI |
ACEI: Angiotensin-converting enzyme inhibitors, ARB: Angiotensin receptor blockers, CCB: Calcium channel blockers, DHP: